Journals / Marmara Medical Journal / 2026 / Volume: 30 Issue: 1

Fallopian tube metastasis in a patient with a history of breast cancer

Pages
—
Publication Date
2017-01-15
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Pathology findings revealed cytokeratin (CK) 7, ER, and PR positive tumor cells.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Breast carcinoma metastasis to the fallopian tube is extremely rare.
📊
Key Findings & Data:Herein, we report a 46-year-old woman with a history of left modified radical mastectomy for breast cancer 13 years ago, presenting with a left adnexial mass.
💡
Conclusion & Impact:Pathology findings revealed cytokeratin (CK) 7, ER, and PR positive tumor cells.
🔬Design:Case Report
📍Scope:Comprehensive Sample
⚙️Variables:Fallopian tube cancer · Breast cancer · Fallopian tube metastasis

Abstract

Breast carcinoma metastasis to the fallopian tube is extremely rare. Distinction between a primary fallopian tumor and metastasis of breast cancer is crucial since treatment and prognosis are different. However, it is difficult to confirm pathologically without surgery. Herein, we report a 46-year-old woman with a history of left modified radical mastectomy for breast cancer 13 years ago, presenting with a left adnexial mass. She underwent total abdominal hysterectomy with bilateral salpingo-oophorectomy. Pathology findings revealed cytokeratin (CK) 7, ER, and PR positive tumor cells. Mammoglobuline, P53, CK20, GCDFP-15 and, thrombomoduline were negative. HER2 was also 2+. Fluorescence in situ hybridization (FISH) for HER2 was negative. Based on the morphology and immunophenotype of the tumor, we established the diagnosis as metastasis of breast cancer to the fallopian tube.

🔖

Cite This Article

Eryılmaz, M. K., Müsri, F. Y., Salim, D. K., Ünal, B., Erdoğan, G., Kaba, M., Coşkun, H. Ş. (2017). Fallopian tube metastasis in a patient with a history of breast cancer. Marmara Medical Journal, Volume: 30 Issue: 1. https://doi.org/10.5472/marumj.299425

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Early Breast Cancer Trialists’ Collaborative Group
  2. (EBCTCG). Effects of chemotherapy and hormonal therapy
  3. for early breast cancer on recurrence and 15-year survival:
  4. an overview of the randomised trials. Lancet 2005;365:1687-
  5. doi: 10.1016/S0140-6736(05)66544-0.